Amgen Inc. buy Wells Fargo & Company
Start price
13.03.23
/
50%
€219.90
Target price
13.03.24
€247.40
Performance (%)
14.78%
End price
14.03.24
€252.40
Summary
This prediction ended on 14.03.24 with a price of €252.40. The prediction had a final performance of 14.78%. A total of €7.97 was paid as dividends for this prediction. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Amgen Inc. | 2.786% | 2.786% | 33.124% |
iShares Core DAX® | 2.749% | 4.620% | 17.121% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $265.00 price target on the stock, down previously from $275.00.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten